Evolent Health (EVH) Accumulated Depreciation & Amortization (2013 - 2026)

Evolent Health has reported Accumulated Depreciation & Amortization for 13 years, with the latest figure at $21.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Depreciation & Amortization fell 10.4% year-over-year to $21.6 million; the trailing twelve-month figure through Mar 2026 stood at $21.6 million (down 10.4% YoY), and the FY2025 full-year result was $115.9 million, down 2.13% from the prior year.
• Accumulated Depreciation & Amortization for Q1 2026 stood at $21.6 million, down from $115.9 million in the prior quarter.
• The five-year high for Accumulated Depreciation & Amortization was $123.4 million in Q4 2023, with the low at $15.1 million in Q1 2022.
• Average Accumulated Depreciation & Amortization over 5 years is $61.4 million, with a median of $59.4 million recorded in 2024.
• Year-over-year, Accumulated Depreciation & Amortization surged 103.22% in 2023 and declined 20.5% in 2025.
• Tracing EVH's Accumulated Depreciation & Amortization over 5 years: stood at $67.2 million in 2022, then jumped by 83.67% to $123.4 million in 2023, then dropped by 4.09% to $118.4 million in 2024, then fell by 2.13% to $115.9 million in 2025, then slumped by 81.39% to $21.6 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $21.6 million (Q1 2026), $115.9 million (Q4 2025), and $70.8 million (Q3 2025), per Business Quant data.

Peer Comparison